康臣药业(01681)12月17日斥资264.22万港元回购17.8万股

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Company Actions - 康臣药业 plans to repurchase 178,000 shares at a total cost of HKD 2.6422 million [1] - The buyback price per share is set between HKD 14.78 and HKD 14.96 [1]